Loading…
Getting the latest data.
First TrustSectorsTechnology#25 of 263 by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.1% | +1.8% | +1.0% | +4.4% | +31.2% | +33.5% | +96.6% | +66.3% | +1,042.1% |
| Peer average | −1.2% | +2.0% | −7.3% | −10.1% | +6.1% | +4.9% | +72.6% | +26.1% | — |
| S&P 500 · VOO | −0.4% | +2.6% | −2.3% | −2.1% | +11.5% | +11.6% | +79.3% | +72.7% | — |
$46 of every $1,000 in FBT is Genmab
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GMABGenmab A/S () | Healthcare | 4.56% | $456.03 | 2.7M | $140.4M |
| 2 | ADMAADMA Biologics | Healthcare | 4.18% | $417.56 | 9.7M | $128.5M |
| 3 | REGNRegeneron Pharmaceuticals | Healthcare | 4.16% | $416.29 | 135K | $128.1M |
| 4 | ARGXargenx SE () | Healthcare | 3.89% | $388.63 | 122K | $119.6M |
| 5 | NBIXNeurocrine Biosciences | Healthcare | 3.89% | $388.57 | 706K | $119.6M |
| 6 | ONCBeOne Medicines () | Healthcare | 3.83% | $383.41 | 284K | $118.0M |
| 7 | EXELExelixis | Healthcare | 3.81% | $381.21 | 1.7M | $117.3M |
| 8 | TGTXTG Therapeutics | Healthcare | 3.81% | $380.96 | 1.8M | $117.3M |
| 9 | ALKSAlkermes | Healthcare | 3.78% | $377.98 | 2.5M | $116.3M |
| 10 | AMGNAmgen | Healthcare | 3.68% | $367.84 | 242K | $113.2M |
| 11 | GILDGilead Sciences | Healthcare | 3.63% | $363.00 | 665K | $111.7M |
| 12 | BIIBBiogen | Healthcare | 3.63% | $362.59 | 446K | $111.6M |
| 13 | UTHRUnited Therapeutics | Healthcare | 3.53% | $353.00 | 183K | $108.7M |
| 14 | INCYIncyte | Healthcare | 3.53% | $352.54 | 892K | $108.5M |
| 15 | VRTXVertex Pharmaceuticals Incorporated | Healthcare | 3.48% | $347.58 | 197K | $107.0M |
of the $365B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GMAB | Genmab A/S () | 4.56% |
| 2 | ADMA | ADMA Biologics | 4.18% |
| 3 | REGN | Regeneron Pharmaceuticals | 4.16% |
| 4 | ARGX | argenx SE () | 3.89% |
| 5 | NBIX | Neurocrine Biosciences | 3.89% |
| 6 | ONC | BeOne Medicines () | 3.83% |
| 7 | EXEL | Exelixis | 3.81% |
| 8 | TGTX | TG Therapeutics | 3.81% |
| 9 | ALKS | Alkermes | 3.78% |
| 10 | AMGN | Amgen | 3.68% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 13, 2024 | Dec 31, 2024 | $1.17 |
| Dec 30, 2021 | Jan 10, 2022 | $2.21 |
| Sep 23, 2015 | Sep 30, 2015 | $0.0200 |
| Jun 24, 2015 | Jun 30, 2015 | $0.0650 |
| Mar 25, 2015 | Mar 31, 2015 | $0.0480 |
| Dec 23, 2014 | Dec 31, 2014 | $0.0524 |
| Jun 23, 2008 | Jun 30, 2008 | $0.27 |